| Scott A Longfellow, MD | |
|
3600 Nw Samaritan Dr, Corvallis, OR 97330-5472 | |
| (541) 768-5111 | |
| Not Available |
| Full Name | Scott A Longfellow |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 3600 Nw Samaritan Dr, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124152368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME95401 (Florida) | Secondary |
| 207L00000X | Anesthesiology | MD210831 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tucson Medical Center | Tucson, AZ | Hospital |
| Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ias Arizona Pllc | 7517312648 | 145 |
| Good Samaritan Hospital Corvallis | 1557270725 | 339 |
News Archive
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This
Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.
ZERO - The End of Prostate Cancer recently announced the donation of two mobile health vehicles to LSU Health Sciences Center and Buddhist Tzu Chi Medical Foundation. Through a competitive process, the vehicles have been awarded to two reputable health service providers.
For several years, the national spotlight has shone on the need to prevent and rapidly treat opioid overdoses. But a new study suggests a need for more focus on the risk of alcohol overdoses among people who use opioids of all kinds, as well as cocaine, marijuana and certain prescription drugs.
› Verified 9 days ago
| Entity Name | Pca Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164804258 PECOS PAC ID: 1658675558 Enrollment ID: O20160215000555 |
News Archive
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This
Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.
ZERO - The End of Prostate Cancer recently announced the donation of two mobile health vehicles to LSU Health Sciences Center and Buddhist Tzu Chi Medical Foundation. Through a competitive process, the vehicles have been awarded to two reputable health service providers.
For several years, the national spotlight has shone on the need to prevent and rapidly treat opioid overdoses. But a new study suggests a need for more focus on the risk of alcohol overdoses among people who use opioids of all kinds, as well as cocaine, marijuana and certain prescription drugs.
› Verified 9 days ago
| Entity Name | Ias Arizona Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689359747 PECOS PAC ID: 7517312648 Enrollment ID: O20231010003129 |
News Archive
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This
Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.
ZERO - The End of Prostate Cancer recently announced the donation of two mobile health vehicles to LSU Health Sciences Center and Buddhist Tzu Chi Medical Foundation. Through a competitive process, the vehicles have been awarded to two reputable health service providers.
For several years, the national spotlight has shone on the need to prevent and rapidly treat opioid overdoses. But a new study suggests a need for more focus on the risk of alcohol overdoses among people who use opioids of all kinds, as well as cocaine, marijuana and certain prescription drugs.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott A Longfellow, MD 119 Oakfield Dr, Brandon, FL 33511-5779 Ph: (813) 890-8004 | Scott A Longfellow, MD 3600 Nw Samaritan Dr, Corvallis, OR 97330-5472 Ph: (541) 768-5111 |
News Archive
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This
Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.
ZERO - The End of Prostate Cancer recently announced the donation of two mobile health vehicles to LSU Health Sciences Center and Buddhist Tzu Chi Medical Foundation. Through a competitive process, the vehicles have been awarded to two reputable health service providers.
For several years, the national spotlight has shone on the need to prevent and rapidly treat opioid overdoses. But a new study suggests a need for more focus on the risk of alcohol overdoses among people who use opioids of all kinds, as well as cocaine, marijuana and certain prescription drugs.
› Verified 9 days ago
Dr. Kevin Cuccaro, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 | |
Dr. Kevin J Tarrant, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Dr. Diane M Krueger, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3509 Nw Samaritan Dr Ste 201, Corvallis, OR 97330 Phone: 541-768-4260 | |
Dr. Gregory Craft, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Kathleen Mae Hinds, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 710 Nw 11th St, Corvallis, OR 97330 Phone: 541-754-1507 | |
David Michael Mcgrath, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-757-5111 |